Release
📈 Stocks
Eli Lilly Reports Positive EBGLYSS Data for Atopic Dermatitis Treatment
(25 minutes ago)
Eli Lilly shares gain as new clinical data for EBGLYSS confirms long-term efficacy and reduced topical treatment needs for patients suffering from…